In our research, we have shown that a CCR1 antagonist improves the analgesic properties of morphine, which is in agreement with results obtained in mice with diabetic neuropathy [13] and in rats in a CCI model [18]. The gene discussed is CCR1; the disease is diabetic neuropathy.